ArticleCureus2025
Orbital Myeloid Sarcoma: An Initial Presentation of Acute Myeloid Leukemia With Maturation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Atypical orbital mass as the precursor for myelodysplastic syndrome recurrence: a case report.American journal of ophthalmology case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute myeloid leukemia (AML) is predominantly an adult disease, with significantly lower incidence in children. Myeloid sarcoma (MS), an extramedullary manifestation of AML, can occur in various tissues, though it is exceptionally rare in the orbit. The variable nature of MS complicates its diagnosis and treatment. In this report, we present the case of an eight-year-old boy who exhibited bilateral proptosis and an orbital mass. Initial investigations revealed thrombocytopenia and leukopenia. Imaging tests confirmed an expansive retroorbital lesion. Immunohistochemistry demonstrated positivity for CD34, CD117, and myeloperoxidase (MPO). The mass was ultimately diagnosed as MS. Subsequent bone marrow analysis confirmed AML. This case highlights that MS, although rare, can serve as an initial presentation of AML in pediatric patients. Epidemiology, diagnosis, treatment, and prognosis for MS were discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.